Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alibaba Health Information TechnologyALBHF 51 Return-on-Tangible-Asset is 6.16% as of Mar. 2026, which is 367% above its 10-year median of 1.32. GuruFocus rates ALBHF with a GF Score™ of 51/100 and a GF Value™ of $0.68 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 77.24% on this metric.
The historical rank and industry rank for Alibaba Health Information Technology's Return-on-Tangible-Asset or its related term are showing as below:
ALBHF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -13.44 Med: 1.32 Max: 9.44
Current: 9.09
During the past 13 years, Alibaba Health Information Technology's highest Return-on-Tangible-Asset was 9.44%. The lowest was -13.44%. And the median was 1.32%.
ALBHF's Return-on-Tangible-Asset is ranked better than 77.24% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 2.5
vs ALBHF: 9.09
Alibaba Health Information Technology (OTCPK:ALBHF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Alibaba Health Information Technology Return-on-Tangible-Asset Related Terms
Alibaba Health Information Technology Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology Return-on-Tangible-Asset Chart
Alibaba Health Information Technology Return-on-Tangible-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 6.16% mean?
Alibaba Health Information Technology (ALBHF) has a Return-on-Tangible-Asset of 6.16% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Alibaba Health Information Technology and its competitors. This is 367% above median its historical median of 1.32. According to the industry distribution chart, Alibaba Health Information Technology ranks #155 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 22.8%.
Is Alibaba Health Information Technology's Return-on-Tangible-Asset too high?
Alibaba Health Information Technology's current Return-on-Tangible-Asset of 6.16% is 367% above median its 10-year median of 1.32. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.50. Alibaba Health Information Technology's value of 6.16% is 146.4% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #155 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #155 out of 681 companies for Return-on-Tangible-Asset. This places Alibaba Health Information Technology in the top 23% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.50. Alibaba Health Information Technology's value of 6.16% is 146.4% above this benchmark. While the company's 10-year median is 1.32 vs. the industry median of 2.50, Alibaba Health Information Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.50, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current Return-on-Tangible-Asset of 6.16% is 146.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current Return-on-Tangible-Asset is 6.16%, which is 367% above median its own 10-year median of 1.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.68, compared to a current price of $0.42 — trading 38.2% below its estimated fair value. The current Return-on-Tangible-Asset is 6.16%, which is 367% above median its 10-year median of 1.32 and 146.4% above the Healthcare Providers & Services industry median of 2.50. Alibaba Health Information Technology's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current Return-on-Tangible-Asset is 6.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $0.42 is trading 38.2% below its estimated GF Value™ of $0.68.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBHF:
Return-on-Tangible-Asset: 6.16% (367% above median its 10-year median of 1.32)
GF Value™: $0.68 vs. price of $0.42 (38.2% below fair value)
Industry Position: 146.4% above the Healthcare Providers & Services median (#155 of 681)
No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health Information Technology Business Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
51GF Score
Get the complete analysis for ALBHF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBHF has been successfully added to your 
